tiprankstipranks
Trending News
More News >
Surgical Innovations (GB:SUN)
LSE:SUN
UK Market

Surgical Innovations (SUN) Stock Statistics & Valuation Metrics

Compare
7 Followers

Total Valuation

Surgical Innovations has a market cap or net worth of £6.53M. The enterprise value is 7.57M.
Market Cap£6.53M
Enterprise Value7.57M

Share Statistics

Surgical Innovations has 932,816,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding932,816,160
Owned by Insiders
Owned by Institutions

Financial Efficiency

Surgical Innovations’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -7.54%.
Return on Equity (ROE)-0.23
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-7.54%
Return on Capital Employed (ROCE)-0.08
Revenue Per Employee149.31K
Profits Per Employee-24.29K
Employee Count80
Asset Turnover0.98
Inventory Turnover2.87

Valuation Ratios

The current PE Ratio of Surgical Innovations is -2.64. Surgical Innovations’s PEG ratio is 0.01.
PE Ratio-2.64
PS Ratio0.00
PB Ratio0.76
Price to Fair Value0.60
Price to FCF-46.31
Price to Operating Cash Flow-88.24
PEG Ratio0.01

Income Statement

In the last 12 months, Surgical Innovations had revenue of 11.95M and earned -1.94M in profits. Earnings per share was 0.00.
Revenue11.95M
Gross Profit3.44M
Operating Income-791.00K
Pretax Income-2.05M
Net Income-1.94M
EBITDA-99.00K
Earnings Per Share (EPS)0.00

Cash Flow

In the last 12 months, operating cash flow was -74.00K and capital expenditures -67.00K, giving a free cash flow of -141.00K billion.
Operating Cash Flow-74.00K
Free Cash Flow-141.00K
Free Cash Flow per Share>-0.01

Dividends & Yields

Surgical Innovations pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.21
52-Week Price Change7.69%
50-Day Moving Average0.67
200-Day Moving Average0.58
Relative Strength Index (RSI)94.74
Average Volume (3m)854.58K

Important Dates

Surgical Innovations upcoming earnings date is Sep 23, 2025, TBA (Confirmed).
Last Earnings DateMar 20, 2025
Next Earnings DateSep 23, 2025
Ex-Dividend Date

Financial Position

Surgical Innovations as a current ratio of 1.88, with Debt / Equity ratio of 14.52%
Current Ratio1.88
Quick Ratio0.83
Debt to Market Cap0.10
Net Debt to EBITDA-10.56
Interest Coverage Ratio-7.99

Taxes

In the past 12 months, Surgical Innovations has paid -107.00K in taxes.
Income Tax-107.00K
Effective Tax Rate0.05

Enterprise Valuation

Surgical Innovations EV to EBITDA ratio is -62.38, with an EV/FCF ratio of -15.10.
EV to Sales0.52
EV to EBITDA-62.38
EV to Free Cash Flow-15.10
EV to Operating Cash Flow-83.45

Balance Sheet

Surgical Innovations has £195.00K in cash and marketable securities with £1.24M in debt, giving a net cash position of £1.04M billion.
Cash & Marketable Securities£195.00K
Total Debt£1.24M
Net Cash£1.04M
Net Cash Per Share<£0.01
Tangible Book Value Per Share<£0.01

Margins

Gross margin is 28.77%, with operating margin of -6.62%, and net profit margin of -16.27%.
Gross Margin28.77%
Operating Margin-6.62%
Pretax Margin-17.16%
Net Profit Margin-16.27%
EBITDA Margin-0.83%
EBIT Margin-16.33%

Analyst Forecast

The average price target for Surgical Innovations is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-0.57%
EPS Growth Forecast-320.00%

Scores

Smart ScoreN/A
AI Score60
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis